O

Oncolys Biopharma Inc
TSE:4588

Watchlist Manager
Oncolys Biopharma Inc
TSE:4588
Watchlist
Price: 1 718 JPY 3.18%
Market Cap: 49.2B JPY

Wall Street
Price Targets

Price Targets Summary
Oncolys Biopharma Inc

There are no price targets for Oncolys Biopharma Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Oncolys Biopharma Inc Competitors:
Price Targets
ATX
Amplia Therapeutics Ltd
176% Upside
2157
Lepu Biopharma Co Ltd
83% Upside
LTRN
Lantern Pharma Inc.
476% Upside
196170
Alteogen Inc
15% Upside
DAWN
Day One Biopharmaceuticals Inc
124% Upside
CGON
CG Oncology Inc
43% Upside
PTCT
PTC Therapeutics Inc
9% Upside
301047
Sino Biological Inc
1% Downside

Revenue
Forecast

Revenue Estimate
Oncolys Biopharma Inc

For the last 13 years the compound annual growth rate for Oncolys Biopharma Inc's revenue is -13%. The projected CAGR for the next 1 year is -93%.

-13%
Past Growth
-93%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oncolys Biopharma Inc

Operating Income forecast
is not available for
Oncolys Biopharma Inc

Net Income
Forecast

Net Income Estimate
Oncolys Biopharma Inc

Net Income forecast
is not available for
Oncolys Biopharma Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Oncolys Biopharma Inc's stock price target?
Not Available

Oncolys Biopharma Inc doesn't have any price targets made by Wall Street professionals.

What is Oncolys Biopharma Inc's Revenue forecast?
Projected CAGR
-93%

For the last 13 years the compound annual growth rate for Oncolys Biopharma Inc's revenue is -13%. The projected CAGR for the next 1 year is -93%.

Back to Top